John Litchfield
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 15
- Drug Transport and Resistance Mechanisms 14
-
- Diabetes Treatment and Management 6
- Diabetes Management and Research 3
- Co-authors
- John Baynes (4 shared papers)Suzanne R. Thorpe (4 shared papers)Kevin J. Wells‐Knecht (2 shared papers)David V. Zyzak (2 shared papers)Manthena V. S. Varma (11 shared papers)Bo Feng (5 shared papers)Theunis C. Goosen (4 shared papers)Ayman El‐Kattan (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Drug Metabolism and Disposition (7 papers)Journal of Medicinal Chemistry (2 papers)ACS Medicinal Chemistry Letters (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
John Litchfield
37 papers receiving 1.8k citations
John Litchfield's Hit Papers
Peers
Comparison fields: 5 of 103
- Clinical Biochemistry 588
- Pharmacology 307
- Endocrinology, Diabetes and Metabolism 354
- Oncology 480
- Biochemistry 117
Countries citing papers authored by John Litchfield
This map shows the geographic impact of John Litchfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Litchfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Litchfield more than expected).
Fields of papers citing papers by John Litchfield
This network shows the impact of papers produced by John Litchfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Litchfield. The network helps show where John Litchfield may publish in the future.
Co-authors
The 25 scholars most cited alongside John Litchfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose Hit paper breakdown → | 1995 | 508 |
| 2 | 1996 | 143 | |
| 3 | 2012 | 107 | |
| 4 | 2017 | 105 | |
| 5 | 2011 | 100 | |
| 6 | 2010 | 84 | |
| 7 | 2011 | 72 | |
| 8 | 2009 | 68 | |
| 9 | 2003 | 64 | |
| 10 | 2013 | 52 | |
| 11 | 2012 | 46 | |
| 12 | 2017 | 42 | |
| 13 | 2013 | 38 | |
| 14 | 2013 | 35 | |
| 15 | 2011 | 34 | |
| 16 | 1999 | 33 | |
| 17 | 2011 | 23 | |
| 18 | 2019 | 22 | |
| 19 | 2019 | 18 | |
| 20 | 2014 | 18 |
About John Litchfield
John Litchfield is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology and Surgery, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (10 papers), Pancreatic function and diabetes (8 papers), Diabetes Treatment and Management (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Advanced Glycation End Products research (4 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Clinical Biochemistry (588 citations), Pharmacology (307 citations), Endocrinology, Diabetes and Metabolism (354 citations), Oncology (480 citations) and Biochemistry (117 citations). John Litchfield has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include John Baynes, Suzanne R. Thorpe, Kevin J. Wells‐Knecht, David V. Zyzak, Manthena V. S. Varma, Bo Feng, Theunis C. Goosen, Ayman El‐Kattan, Charles J. Rotter and David A. Tess. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Drug Metabolism and Disposition, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.